Target intelligence / Profile preview

GRAM domain-containing protein 2A (GRAMD2A)

Target
GRAMD2A
Molecular classification
Other (ER-plasma membrane tethering protein), Membrane contact site protein, GRAM domain protein
01

Overview

GRAM domain-containing protein 2A (GRAMD2A) is a mammalian membrane protein characterized by a GRAM domain and a transmembrane region, anchoring it to the endoplasmic reticulum. It operates at membrane contact sites, specifically tethering the ER to the plasma membrane via direct binding of its GRAM domain to phosphatidylinositol 4,5-bisphosphate in the plasma membrane. GRAMD2A is essential for the recruitment of stromal interaction molecule 1 (STIM1), facilitating the store-operated calcium entry (SOCE) pathway, which is a critical component of intracellular calcium regulation. Unlike other LAM family members, GRAMD2A lacks a VASt (sterol transfer) domain and is primarily associated with spatial organization of ER-plasma membrane contact sites destined for SOCE. It marks a subset of highly specialized ER-PM domains and participates in calcium signaling through organizational rather than enzymatic or receptor-mediated functions. No evidence currently positions GRAMD2A as a major therapeutic target or biomarker. It is structurally critical for calcium homeostasis but is functionally redundant with other ER-PM tethers, and absence of GRAMD2A leads to compensatory mechanisms within the cell, without dramatic functional loss or disease association.

Other names
GRAMD2AGRAMD2GRAM domain containing 2AGRAM domain-containing protein 2A
02

Biological functions

Endoplasmic reticulum-plasma membrane tetheringRegulation of store-operated calcium entry (SOCE)Phosphatidylinositol-4,5-bisphosphate bindingCalcium homeostasis
03

Disease associations

Other (No clear evidence exists linking GRAMD2A directly to cancer, inflammation, or other major disease categories as a driver or biomarker based on current literature)

Beyond the preview

Go deeper on GRAM domain-containing protein 2A (GRAMD2A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GRAM domain-containing protein 2A (GRAMD2A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call